Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.

被引:32
作者
Zhang Q. [1 ]
Yang Y.M. [1 ]
Lv X.Y. [1 ]
机构
[1] Department of Very Important People, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou
来源
Journal of Zhejiang University SCIENCE B | 2006年 / 7卷 / 11期
关键词
Graves’ ophthalmopathy; Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) gene; Gene frequency; Susceptibility gene; R581.1;
D O I
10.1631/jzus.2006.B0887
中图分类号
学科分类号
摘要
OBJECTIVE: To investigate the association of Graves' disease and Graves' ophthalmopathy with the C/T transition polymorphism at position -318 of promoter and the A/G transition polymorphism at position 49 of exon 1 within cytotoxic T lymphocyte associated antigen-4 (CTLA-4) gene. METHODS: Thirty-three patients with ophthalmopathy of Graves' disease, fifty-six Graves' patients without ophthalmopathy and sixty normal subjects as control were involved in the present case-control study. The polymorphisms were evaluated by polymerase chain reaction fragment length polymorphism (PCR-RFLP). Comparisons were made of gene frequencies and allele frequencies between the groups. RESULTS: The gene frequencies of CT and allele frequencies of T were much higher in Graves' patients with ophthalmopathy than that in the group without ophthalmopathy (P=0.020, P=0.019). The gene frequencies of GG and allele frequencies of G in patients with Graves' disease were significantly increased as compared with control group (P=0.008, P=0.007). The data suggest that smokers with Graves' disease seemed to be more predisposed to ophthalmopathy than non-smokers (P=0.018). CONCLUSION: Our results suggest that an allele of T at position -318 of promoter is associated with genetic susceptibility to Graves' ophthalmopathy while an allele of G at position 49 of exon 1 is associated with genetic susceptibility to Graves' disease instead. Smoking is believed to be a major risk factor for ophthalmopathy.
引用
收藏
页码:887 / 891
页数:4
相关论文
共 85 条
[1]  
Allahabadia A.(2001)MHC class II region, CTLA-4 gene, and ophthalmopathy in patients with Graves’ disease Lancet 358 984-985
[2]  
Heward J.M.(1998)Cigarette smoking and treatment outcomes in Graves’ ophthalmopathy Ann. Intern. Med. 129 632-635
[3]  
Nithiyananthan R.(1998)CTLA-4 promoter variants in patients with Graves’ disease and Hashimoto’s thyroiditis Tissue Antigens 51 563-566
[4]  
Gibson S.M.(1997)Superoxide radical production stimulates retroocular fibroblast proliferation in Graves’ ophthalmopathy Exp. Eye Res. 65 311-316
[5]  
Reuser T.T.(1996)An Msul RFLP in the human CTLA-4 promoter Biochem. Biophys. Res. Commun. 225 817-818
[6]  
Dodson P.M.(1997)CTLA-4 alanine-17 confers genetic susceptibility to Graves disease and to type 1 diabetes mellitus J. Clin. Endocrinol. Metab. 82 143-146
[7]  
Franklyn J.A.(2001)CTLA-4 gene polymorphisms in Tunisian patients with Graves’ disease Clin. Immunol. 101 361-365
[8]  
Gough S.C.L.(1987)Is endocrine ophthalmopathy related to smoking? Br. Med. J. 295 643-645
[9]  
Bartalena L.(1998)No evidence for allelic association of a human Clin. Endocrinol. (Oxf) 49 331-334
[10]  
Marcocci C.(1999) promoter polymorphism with autoimmune thyroid disease in either population-base case-control or family-based studies Chinese Journal of Endocrinology and Metabolism 15 215-216